Impact of Smoking on Glycemic Status by Ramu, S
IMPACT OF SMOKING ON 
GLYCEMIC STATUS  
 
 
DISSERTATION SUBMITTED FOR 
M.D DEGREE (MEDICINE) BRANCH III 
MARCH 2009 
 
 
 
 
 
 
 
 
 
 
 
 
THE TAMILNADU Dr. M.G.R. MEDICAL UNIVERSITY 
CHENNAI 
CERTIFICATE 
 
This is to certify that the dissertation titled “IMPACT OF 
SMOKING ON GLYCEMIC STATUS” submitted by Dr. S. Ramu  to 
the Faculty of General Medicine, The Tamilnadu Dr. M.G.R. Medical 
university, Chennai in partial fulfillment of the requirement for the 
award of M.D. Degree Branch I (General Medicine) is a bonafide 
research work carried out by him under our direct supervision and 
guidance. 
 
 
 
Dr. A. AYYAPPAN M.D., 
 Professor and H.O.D of Medicine 
 Chief I Medical Unit,  
 Department of Medicine,  
 Madurai Medical College,  
 Madurai. 
 
 3
DECLARATION 
 
 I, Dr. S. Ramu, solemnly declare that the dissertation titled 
“IMPACT OF SMOKING ON GLYCEMIC STATUS" has been 
prepared by me. I also declare, this bonafide work or a part of this work 
was not submitted by me or any other for any award, degree, diploma to 
any other University, board either in India or abroad. 
 
 This is submitted to the Tamilnadu Dr. M.G.R. Medical 
University, Chennai in partial fulfillment of the rules and regulations 
for the M.D. Degree Examination in General Medicine to be held in 
March 2009. 
 
 
 
Place :  Madurai 
Date :           Dr.S.Ramu 
 
 4
ACKNOWLEDGEMENT 
 
 My sincere thanks to The Dean, Dr. S.M. SIVAKUMAR M.S, for 
permitting me to use the facilities of Madurai Medical College and 
Govt. Rajaji Hospital to conduct this study. 
 
 I will ever remain in gratitude to my chief and the H.O.D of 
medicine Dr. A. AYYAPPAN M.D, not only for guiding me through this 
study, but also for being my mentor and source of inspiration during 
the period of my postgraduate training. 
 
 My heartfelt thanks to Dr. J. SANGUMANI M.D.,                            
Dr.S. SOMASUNDARAM M.D., and Dr. L. JERALD MAJELLAH M.D., for 
their valuable support and guidance throughout the study and also for 
making my stay in the unit both informative and pleasurable. 
 
My family and friends have stood by me during my times of 
need. Their help and support have been invaluable to this study. 
 
 I would grossly fail in my duty if I fail to mention here of my 
patients, who have ungrudgingly borne the pain and discomfort of the 
investigations. I cannot but pray for their speedy recovery and place 
this study as a tribute to them and to the numerous others likely 
affected involved during the study period. 
 7
CONTENTS 
 
S.No. Contents Page No. 
1.       Introduction 1 
2. Review of Literature 3 
3. Aim of the Study  30 
4. Materials and Methods 31 
5. Results 36 
6.      Discussion 53 
7.      Summary 60 
8.      Conclusion 61 
9.      Limitations 63 
      Bibliography  
     Appendix I : Proforma   
     Appendix II : Master Chart  
     Appendix III :Ethical committee clearance  
 
 
 
 
 9
INTRODUCTION 
 
 Tobacco use has long been known to be a major risk factor for 
cardiovascular disease. Recent studies have identified a positive association 
between smoking and incidence of diabetes. The evidence that smoking is an 
independent risk factor for the development of diabetes is still considered 
preliminary. Some studies have shown a dose response association between 
smoking and incidence of diabetes; but others have not.   
 
 Several Hypothesis have been proposed to link tobacco use and 
incidence of diabetes. Smoking has been linked to impaired response to 
glucose tolerance tests and insulin resistance. Although, smoking cessation 
can result in modest weight gain, smoking is related to a more unhealthy 
distribution of upper body weight and greater waist – hip ratio. Smoking has 
also been associated with risk of chronic pancreatitis and pancreatic cancer, 
suggesting that tobacco smoke may be directly toxic to pancreas.  
 
       "Heavy smokers are more likely to get diabetes over time than are lighter 
smokers … who are in turn are more likely to get diabetes than non-smokers," 
said by  Dr. William Ghali, one of the review authors. 
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While researchers are hesitant to directly link smoking to the onset  of  
diabetes, they theorize that smoking may "lead to insulin resistance or  
inadequate compensatory insulin secretion responses," according to the 
authors, primarily from the University of Lausanne in Switzerland. Insulin 
resistance means. The body is less able to both store and process glucose, 
causing blood glucose levels to rise and leading to the development of Type 2 
diabetes. 
 
           A number of preliminary studies have assessed the association between 
smoking and incidence of glucose abnormalities, suggesting that active 
smoking could be independently associated with glucose intolerance, 
impaired fasting glucose, and type 2 Diabetes. 
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REVIEW OF LITERATURE 
 
CIGARETTE SMOKING 
Cigarette smoking remains the most important cause of preventable 
morbidity and early mortality. 
 
In 2000, there was an estimated 4.8 million premature deaths in the 
world attributable to smoking, 2.8 million in developing countries and 2 
million in industrialised countries. More than 3/4 (3.8 million) of these deaths 
were in men. The leading causes of death from smoking were 
 
 Cardiovascular diseases  1.7 million deaths 
COPD     1 million deaths 
Lung cancer    0.9 million deaths(CMDT 2008)2 
 
The incidence of smoking is highest in blacks, less educated persons 
and in the lower socio economic status. (Nicotine addiction – article by sat 
Sharma et al)54 
 
Tobacco addiction  (p 2376-Harrison 17th edition)1 
Nicotine, is the principle constituent of Tobacco responsible for its      
addictive character. 
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Addicted smokers regulate their Nicotine intake and blood levels by 
adjusting the frequency and intensify of their Tobacco use. 
 
 Nicotine is highly addictive, raises the Brain Level of Dopamine and 
alters the Bioavailability of Dopamine and Seratonin. It produces withdrawal 
symptoms on discontinuation. 
 
FORMS OF TOBACCO USE 
   Bidi (Tobacco wrapped in tendu (or) TEMBURNI Leaf) 
Smoking         Cigars / Pipe 
   Cigarette  
 
      Chewing tobacco 
Smokless tobacco 
    Snuff 
Smoking (Burned tobacco) – carcinogenic  
Smokeless tobacco (unburned tobacco) – gum disease 
       Oral cancer 
       Slight increase in Heart disease 
Bidi smoking is the most common form of tobacco smoking in India. 
The Bidi is an indigenous smoking stick 4-8cm long, usually containing 0.15 
– 0.25g coarse tobacco flakes rolled in a rectangular piece of dried temburni 
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leaf. The number of bidis produced and consumed in India is 7-8 times higher 
than the number of cigarettes, thus most studies on health risks to smokers in 
India have concentrated on bidi smoking. Moreover, cigarette smoking is 
common generally only in higher socioeconomic groups. Besides cigarettes 
and bidis, other smoking habits includes various indigenous forms of pipe and 
cheroot smoking. Cheroots are small cigars made of heavy bodied cured 
tobacco rolled in a dried tobacco leaf and tied with a thread. (Shapiro et al)55 
 
Chuttas are coarsely prepared cheroots. The length of chuttahs varies 
from 5 to 12 cm. The hookah. (Hooka) is a pipe that allows the tobacco 
smoke to pass through water before the smoker inhales it (Water pipe).  
 
Cigarettes, cigars, spit and pipe tobacco are made from dried tobacco 
leaves, as well as ingredients added for flavor and other reasons. More than 
4,000 different chemicals have been found in tobacco and tobacco smoke. 
Among them more than 60 chemicals known to cause cancer (carcinogens).  
                     
There are hundreds of substances added to cigarettes by manufacturers 
to enhance the flavor or to make smoking more pleasant. Some of the 
compounds found in tobacco smoke include ammonia, tar, and carbon 
monoxide. Exactly what effects these substances have on the cigarette 
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smoker’s health is unknown, but there is no evidence that lowering the tar 
content of a cigarette lowers the health risk. Manufacturers do not usually 
give out information to the public about the additives used in cigarettes, so it 
is hard to know the health risks.  
TYPE OF SMOKING AND ITS IMPACT 
 
Pipes and Cigars 
 
 
 
 
 
 
 
- Alkaline pH of smoke from blends of tobacco utilized for pipes and 
cigars allows significant absorption of Nicotine across oral mucosa.  
 
- Therefore, they tend not to inhale the smoke into the Lung, 
confining the toxic and carcinogenic exposure largely to upper 
airway for most of these products. 
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Cigarettes and Bidis 
 
   
           Acidic pH of smoke from tobacco used in cigarettes and bidis induces  
Nicotine absorption in mouth. 
 
 Therefore, this favours inhalation of smoke in to larger surface of lungs 
in order to absorb quantities of Nicotine sufficient to satisfy smoker’s 
addiction. 
 
This leads to increased deposition in lungs 
           Increased Lung disease 
           Increased Lung cancer 
           Increased Heart disease 
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On comparing the above 
- The risk of upper airway carcinoma is similar among cigarette and 
cigar smokers. 
 
- While, those who have smoked only cigars, have a much lower risk of 
lung carcinoma, heart disease and COPD. 
 
- However, cigarette smokers who switch to pipes / cigars do tend to 
inhale the smoke, increasing their risk. 
 
Nicotine content (Jenifer et al 2001)34 
Chewing tobacco (pan) 3.4 mg / g 
Cigarettes 
       Filtered                16.3 mg /g 
      Unfiltered     13.5 mg / g 
Bidis           21.2 mg / g 
 
 
TYPE OF SMOKING AND ITS IMPACT 
a)Bidis Vs Cigarettes  
Since bidis contain a higher content of nicotine when compared to 
cigarettes, Smoking highlight Bidi leads to more nicotine addiction. 
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b)Filtered Vs unfiltered cigarettes 
Smoking filtered cigarettes lowers disease risk. Smokers however can 
compensate and preserve their intake of nicotine by 
 Changing the manner in which they smoke /puff on cigarette. 
 The number of cigarettes smoked per day 
 
Therefore, no meaningful disease – reduction benefit by smoking filtered 
cigarettes.  
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DISEASE MANIFESTATION IN SMOKING CIGARETTE 
[P. 2736 – Harrison 17th edition 1, P.5 – CMDT 2008 2] 
I. Cardiovascular disease (Large vessel atherosclerosis) 
PVD (90%) 
Aortic aneurysm (50%) 
CAD (20 – 30%) 
Occlusive cerebrovascular disease (10%) 
Increased likelihood of MI and sudden cardiac death ( since it promotes 
platelet aggregation and vascular occlusion) 
 
II. Cancer 
Ca. Lung                           Ca.Kidney (Body + Pelvis ) 
Ca.Oral cavity                      Ureter 
Naso                                  Urinary bladder 
Oro    pharynx                                Uterine cervix  
Hypo 
Nasal cavity   
PNS    
Larynx   
Esophagus 
Stomach 
Pancreas 
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Liver 
Acute myeloid leukemia 
Increased risk for Colorectal cancer and  Premenopausal Breast cancer 
 
III. Respiratory Disease 
COPD (90%) 
 
IV.  Pregnancy 
Maternal complications  
PROM 
    abruptio placentae 
    placenta praevia 
    spontaneous abortion 
Fetal complications 
              Preterm  delivery 
              Increased perinatal mortality 
              Small for gestational age 
               IRDS 
              Sudden infant death syndrome 
 
V  Other conditions 
 Delayed healing of peptic ulcer 
 Increase risk of osteoporosis 
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 Senile cataract 
 Macular degeneration 
 Premature menopause 
 Skin wrinkling 
 gall stones and cholecystitis  
 Male impotence  
 
 
 
 
 
 
 
VI. Environmental tobacco smoke  
¾ Increased risk of lung carcinoma  
¾ Increased risk of CAD 
¾ Increased Resp tract infection 
¾ CSOM 
¾ Asthma exacerbation in children 
¾ Increased cervical cancer  
¾ Increased  Invasive pneumococcal disease. 
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COMPARED TO NON SMOKERS 
Smokers have 
           2 times risk for  fatal heart disease 
           10 times risk for  Lung carcinoma 
           Several times   Ca. Mouth / Throat / Esophagus / Pancreas           
                                                         / Kidney/ Bladder / Cervix 
  
           2 – 3 fold   Stroke / peptic ulcer 
           2 – 4 fold   Fracture Hip / wrist / Vertebrae  
           4 times   Invasive pneumococcal disease 
           2 fold    Cataract  
          2 – 5 times   ARMD (Age Related Macular degeneration) 
         increased risk of  Alzhemier’s disease 
         Death    5 to 8 yrs earlier  
 
 23
 
 24
DIABETES 
 (API text book of Medicine 8th edition – p. 1042) 3 
 Diabetes Mellitus is a metabolic disorder characteristised by 
hyperglycemia resulting from defects in Insulin secretion, Insulin action on 
both. The prevalence of type & diabetes is increasing all over the world 
particularly in the developing countries. It has emerged as a major public 
health problem in our country. The WHO estimated that there were 31.7 
million persons with diabetes in India in 2000 and that the number is likely to 
be 71.4 million in 2030. India has the distinction of having the largest number 
of diabetes in the world. Studies in 1980 highest prevalence rates of type & 
diabetes among migrant ethnic groups, suggesting that Indians as an ethnic 
group had a genetic propensity to develop diabetes which was precipitated by 
lifestyle changes. Current prevalence rates are 12.1% in the urban population. 
There is evidence that the prevalence of type 2 diabetes in increasing in rural 
population also. 
 
 Type 2 diabetes amongst Indians occurs at a younger age, the age at 
diagnosis being a decade earlier than in the west. Body mass indeed is lower 
by 4 kg/m2 in male and 6 kg/m2 in female. However abdominal obesity with 
increased waist to hip ratio is more common. 
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SMOKING AND DIABETES 
 There is a growing body of evidence that smoking is an Independent 
risk factor for diabetes, and that among people with diabetes, smoking 
aggravates the risk of serious disease and premature death. 
 
 In the Us Nurses Health Study, 114,247 women were followed for       
8 years and 2,333 cases of type 2 diabetes were confirmed. After controlling 
for multiple risk factors, the relative risk of diabetes was 1.42 among women 
who smoked ≥ 25 cigarettes a day compared with non-smokers, suggesting a 
moderate association between smoking and the subsequent development of 
diabetes (Rimm, E.B. et al. 1993).50 
 
 A similar study of 41,810 middle aged men found that those who 
smoked > 25 cigarettes daily had a relative risk of  diabetes of 1.94 compared 
with non smokers. (Rimm, E.B. et al 1995).49 
 
 A prospective study of Japanese men concluded that age of Smoking 
initiation and number of cigarettes smoked were major risk factors for 
developing diabetes (Kawakami, N. et al 1997).35 
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 Similarly, data from the US cancer prevention study found that as 
smoking increased so the rate of diabetes increased for both men and women 
(Will JC et al. 2001).70 
 
 Another study found that smokers had a 44% increased risk of type 2 
diabetes compared with non-smokers with the risk raising with number of 
cigarettes smoked. 
 
 The Journal of American Medical association study found the 
increased risk for those who smoked at least 20 cigarettes a day rose to 61%. 
For lighter smokers the risk was 29% higher than for a non smokers. 
 
             The findings from these studies are consistent with a positive 
association between the number of cigarettes smoked per day and the 
incidence of diabetes mellitus in both men and women. However, in the age-
adjusted data, the evidence of a dose-response relation is limited and the effect 
is largely confined to those smoking more than two packs of cigarettes per 
day. The increased risk of diabetes observed in smokers remained significant 
on adjustment for potential confounders including body mass index (BMI) at 
baseline, alcohol use, race, amount of exercise, educational level and dietary 
intakes of fats and carbohydrate. On quitting smoking, rates of diabetes fell 
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gradually to that of non-smokers, providing some evidence of reversibility of 
the effect. 
 
SMOKING AND HBA1C LEVELS 
 
              Given the problems of interpretation associated with prospective 
studies of incident cases of diagnosed diabetes, the data from Sargent et al. are 
illuminating. This work is based on cross-sectional analysis of the association 
between cigarette smoking and haemoglobin A1C in 2704 men and 3358 
women aged 45 to 74 who were recruited into the East Anglian component of 
the European Prospective Investigation into Cancer (EPIC-Norfolk). 
Participants with known diabetes were excluded from the analyses. Mean 
haemoglobin A1C concentrations (a marker of long-term glucose homeostasis) 
were lowest in never smokers, intermediate in former smokers and highest in 
current smokers. There was a ‘dose-response relationship between 
haemoglobin A1C levels and both the number of cigarettes smoked per 
day and with total smoking as measured by pack-years’. This association 
persisted in analysis adjusted for a range of potential confounders including 
BMI, waist-hip ratio, physical activity (based on an instrument with 
acceptable and well documented reliability and validity) and dietary variables, 
assessed using a standard food frequency questionnaire and plasma vitamin C 
concentration. In men, mean haemoglobin A1C fell with increasing time since 
quitting smoking. The association between smoking and haemoglobin A1C 
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levels persisted in analysis from which individuals reporting major illnesses 
were excluded. 
 
Smoking and Insulin resistance 
 
               Smoking has also been identified as a risk factor for Insulin 
resistance which can lead to diabetes. Smoking may directly increase Insulin 
resistance. Insulin response to an oral glucose load was more pronounced in 
smokers than in non smokers. (Facchini Fs et al. 1992).21 Insulin resistance 
was dose – dependently related to smoking (Eliasson B et al 1994).19 
 
 Further more smokers had features of Insulin resistance syndrome, 
including Low HDL cholesterol and high fasting glucose (Dzien et al 2004).17 
 
 Metabolic syndrome was shown to be associated with smoking. In a 
cross sectional study, male smokers had higher rates of metabolic syndrome 
than did non smokers (Geslain et al 2003).24 
 
 Among US adolescents 12 – 19 yrs old, the prevalence of metabolic 
syndrome increased with tobacco exposure. (Weitzman M et al 2005).69 
 
 Smoking leads to accumulation of visceral fat and then, to Insulin 
resistance. This association may be partly explained by a confounding with  
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low degree of physical activity and unhealthy diet frequently encountered 
among smokers. 
 
 
 
 
 
 
 
 
Smoking Low physical activity 
Unhealthy diet
Visceral fat accumulationInsulin resistance
Metabolic syndrome
Type 2  Diabetes
ACUTE CHRONIC
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Smoking and Waist Circumference 
 Waist circumference (WC) or Waist – Hip ratio (WHR) is an indicator 
of visceral adipose tissue (VAT). A greater amount of VAT is related to 
metabolic syndrome, diabetes and cardiovascular diseases (Han Ts et al 
2006).25 Cross-sectional studies indicate that WHR higher in smokers than in 
non-smokers. (Bamia C et al 2004).7 WHR is positively associated with 
number of pack – years of smoking (Rosmond et al 1999)51 and ‘there is a 
dose response relation between WHR and the number of cigarettes 
smoked’. 
 
 In particular, smokers had to have both a larger waist circumference 
and a smaller hip circumference than do non- smokers. This combination of 
high WHR and Low BMI is a “paradox” is found more frequent in smokers 
than in non-smokers. 
 
The relationship between smoking and obesity is incompletely 
understood. On one hand, nicotine acutely increases energy expenditure 
(Hofstetter et al., NEJM 1986)30 and could reduce apetite, which likely 
explains why smokers tend to have lower body weight than do nonsmokers 
and why smoking cessation is frequently followed by weight gain(Ward KD 
et al., 2001).68 
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            Moreover, a popular belief among both smokers and nonsmokers is 
that smoking is an efficient way to control body weight(Potter BK et al., 
2004).45On the other hand, studies indicate that heavy smokers(i.e., those 
smoking a greater number of cigarettes/day) have a greater body weight than 
do light smokers. 
            
European congress of endocrinology 2006 evaluated the association 
between smoking and BMI, where they found that smokers had a lower BMI 
compared to nonsmokers. But among the smokers, BMI increased in 
proportion to the number of cigarettes smoked (cross sectional study). They 
have also done a longitudinal study, where they found that all smoking 
subgroups had an increased BMI. 
 
At last they concluded by stating that, there is an U-shaped relationship 
between smoking and BMI. Heavy smoking is associated with an unhealthy 
lifestyle, which appeared to override the weight reducing effect of cigarette 
smoking. 
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Possible Mechanism 
Smokers → Higher fasting plasma cortisol concentration that did non        
                                smokers (Cryer PE et al).14 
                                                  ↓ 
                              Influences Visceral adipose tissue. 
 
The link between cigarette smoking and abnormalities of glucose 
Homeostasis is biologically plausible, as several studies have suggested that 
smoking may directly impair insulin sensitivity, One of the key determinants   
of glucose tolerance. (Ronnemaa T et al 1996).52 
 
 Smoking also found to reduce over all obesity but accentuates central 
deposition of fat (Slattery et al. 1993).57 Another explanation for apparent 
effect of cigarette smoking on glucose tolerance would be through increased 
oxidative stress. This is known to be increased in cigarette smoking (Rahman 
I et al 1996)48 and experimental evidence suggests that increased oxidative 
stress impair  Insulin action. (Paolissa G et al 1996).44 
 
 In another large population – based study, cigarette smoking was 
independently associated with higher HbA1C concentration in both men 
and women. (Lincoln et al 2001).38 
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It has been found that smoking is a risk factor for type 2 diabetes, 
independently of BMI and physical activity [BMJ 2006; 332 (6 may)] 31 
 
The effect of smoking on the incidence of glucose intolerance occurred 
irrespective of waist hip ratio and baseline insulin that have been associated 
with development of diabetes. (Pederson et al).45  
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POSSIBLE MECHANISMS OF SMOKING & DIABETES 
a)Smoking  →  activates  sympathetic system   →   Higher fasting plasma                
                                        ↓                                        Cortisol concentration 
                  Increased catecholamines                                   ↓                        
                                        ↓                           influences visceral adipose tissue 
 Inhibits insulin mediated Uptake of glucose                       ↓ 
                                       ↓ 
 
 Insulin resistance                               insulin resistance 
 
  
b)Smoking     →    Low physical activity and unhealthy diet 
                                                 ↓ 
                                          
                          Visceral fat accumulation       →                insulin resistance 
 
 
c)Smoking     →         direct influence on  insulin  sensitivity  by  increasing    
 
                                    oxidative stress         
                                      
                                          ↓ 
                             
                                  impaired insulin action 
 
d) smoking           →           metabolic syndrome 
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SMOKING IN DIABETES 
     
Smokers are insulin resistant, exhibit several aspects of the insulin 
resistance syndrome, and are at an increased risk for type 2 diabetes.  
 
Many patients with type 1 and type 2 diabetes mellitus are at risk for 
micro- and macrovascular complications.  
 
              Cigarette smoking increases this risk for diabetic nephropathy, 
retinopathy, and neuropathy, probably via its metabolic effects in combination 
with increased Inflammation and endothelial dysfunction. This association is 
strongest in type 1 diabetic patients.  
 
The increased risk for macrovascular complications, coronary heart 
disease (CHD), stroke, and peripheral vascular disease, is most pronounced in 
type 2 diabetic patients.  
 
The development of type 2 diabetes is another possible consequence of 
cigarette smoking, besides the better-known increased risk for cardiovascular 
disease. In diabetes care, smoking cessation is of utmost importance to 
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facilitate glycemic control and limit the development of diabetic 
complications. 
 
BENEFITS OF SMOKING CESSATION 
  There is an overwhelming evidence that stopping smoking reduces the 
risk of cardiovascular disease, lung disease, cancer and stroke (Us department 
of health and human services 1990).63 
As diabetes increases the risk for heart disease and stroke, it follows 
that stopping smoking will reduce the risk of complications from diabetes 
such as heart disease.            
  Few studies have evaluated smoking cessation treatment specifically 
for people with diabetes but the limited research available suggests that 
smokers with diabetes may be less successful in quitting than smokers 
without diabetes and that intensive strategies  should be considered to 
optimise successful cessation(Haire-josu D et al.,1999)28 
               One possible explanation for the lower quitting rates among people 
with diabetes is the fact that stopping smoking is associated with weight gain 
and this is likely to be of concern in people who have diabetes and are already 
overweight.  
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               One US study found that concerns about weight gain among 
smokers with Type 1 diabetes were particularly prevalent among women, 
obese smokers, and those in poor metabolic control(Haire-joshu D et al)27 
Fear of weight gain was cited by 49% of smokers.  
          A recent British prospective study of 7,735 men aged 40-59 years found 
that cigarette smoking was associated with a significant increase in risk of 
diabetes, even after adjustment for age, body mass index, and other potential 
confounding factors.  The benefit of giving up smoking was only apparent 
after  5 years of smoking cessation and risk reverted to that of never-smokers 
only after 20 years.  Men who gave up smoking during the first 5 years of 
follow-up showed significant weight gain and subsequently higher risk of 
diabetes than continuing smokers.  However, the authors concluded that in the 
long term, the benefits of giving up smoking outweigh the adverse effects of 
early weight gain(Wannamethee SG et al .,2001)66 
Stopping smoking also reduces the risk of premature death.  The US 
Nurses’ Study found that among women with Type 2 diabetes who had 
stopped smoking for 10 or more years had a mortality relative risk of 1.11 
compared with diabetic women who were never smokers (Al Delaimy W.K. 
et al 2001)4  
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In the light of the growing evidence demonstrating that smoking is an  
independent risk factor for diabetes and that it is also an aggravating  factor 
for diabetes complications, smoking cessation advice should be a routine 
component of diabetic care.  Concerns about weight gain should be addressed 
by health care providers whilst emphasising the fact that the health benefits of 
smoking cessation far outweigh post cessation weight gain, even in people 
who are focused on weight management.  
 39
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AIM OF THE STUDY 
 
 
 To assess whether smokers are more likely than non smokers to     
     develop clinically relevant glucose intolerance or diabetes.  
 
 To assess whether total pack years correlates with the severity of 
glucose intolerance/ diabetes. 
 
 To assess whether the various types of tobacco smoking (Bidis, 
Cigarettes or both) have an influence on the development of glucose 
intolerance / diabetes. 
 
 To assess the relationship between smoking and obesity and thereby to 
find an indirect evidence of insulin resistance. 
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MATERIALS AND METHODS 
 
Design of study  : Cross sectional study 
 
Period of study  : June 2007 – June 2008 
 
Sample size                          :          150 patients 
 
Selection of subjects : Patients attending Government Rajaji                      
                                                        Hospital of age 18 – 60 yrs. 
 
Data Collection  : Socio demographic 
     Clinical 
     Biochemical 
     Anthropometry 
 
Methods   : Standard clinical and laboratory methods. 
 
Consent   : Informed consent was obtained from all  
patients or relatives.  
 
Inclusion Criteria 
All smokers attending Govt. Rajaji Hospital from 18 – 60 years of age. 
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Exclusion criteria 
 Known diabetes  
 Alcoholics 
 Pregnancy 
 Age < 18 and > 60 years. 
 Acute stressful situations such as  
   - Myocardial infarction 
   - Trauma 
   - Severe Infection  
 Patients on drugs such as 
   - Steroids 
   - OCP 
                                 - Thiazide diuretics 
    
Clinical materials 
- Weight  
- Height 
- BMI 
- Waist circumference 
- Hip circumference 
- Waist hip ratio 
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Laboratory materials 
 The following investigations were done for all the patients  
   (F) 
Blood sugar 
   (PP) 
 
Fasting Lipid profile 
   TC 
   TGL 
   HDL 
   VLDL 
   LDL 
 
Methods 
 We have evaluated HUNDRED smokers and FIFTY nonsmokers 
Baseline characteristics of the study are as follows; age, sex, occupation, 
Education status, family history of diabetes, comorbid illness of smoking. Our 
Baseline examination included Ht, Wt, BMI, BP, HC, WC, Waist Hip ratio 
(anthropometric measurements), Lab investigation – Blood sugar (F and PP) 
and Lipid profile  
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Definition of Baseline tobacco exposure  
 Participants were defined as current smokers and former smokers. 
Former smoker were those who, at baseline, reported previously using 
cigarettes but denied current smoking. 
 
Definition of outcomes 
   Guidelines from the American Diabetes association defined 
Impaired fasting glucose as serum glucose 
≥100mg / dl and < 126 mg / dl 
Diabetes as fasting serum   glucose  
≥ 126 mg / dl 
 
    Body mass index defined as  Wt (kg) 
              Ht (m2) 
            Normal < 25 kg / m2 
            Over weight 25.0 – 29.9 
            Obesity > 30 
            Extreme obesity > 40 
Pack Years is defined as  
Number of cigarettes smoked per day    x    Numbers of years smoked  
                              20 
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Metabolic syndrome  :  NCEP : ATPIII 2001 guidelines  
 
Presence of > 3 of the following  is  diagnostic of  metabolic  syndrome 
 
• Central obesity   :  Waist circumference > 102 cm (M) / > 88cm (F) 
 
• Increased Triglycerides :  Fasting Triglycerides > 150mg / dl 
 
• Decreased HDL      : < 40 mg / dl (Male) 
               < 50 mg / dl (Female) 
 
• Hypertension       : Blood pressure    Systolic BP≥ 130mmHg    
                                                                                 (or) 
              Diastolic ≥ 85 mg 
 
• Fasting plasma glucose : > 100mg / dl (or) previously diagnosed 
type 2 DM 
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RESULTS 
A. PROFILE OF CASES STUDIED  
Table 1 
Age Distribution 
Smokers – 100 Non Smokers – 50  
Age Groups 
No % No % 
Upto 30 years 7 7 2 4 
31 – 40 years 23 23 5 10 
41 – 50 years 32 32 28 56 
51 – 60 years 38 38 15 30 
Total 100 100 50 100 
Mean 47.34 Years 47.62 Years 
S.D 10.76 years 6.89 years 
               ‘p’ value  0.8091 
Not significant 
 
Age of the study population ranged from 15 – 65 years. Majority of 
them were between 3rd and 5th decade (85%). Mean age of cases were 47.34 in 
our study. Mean age of controls were 47.62 in our study. Thus there was no 
significant difference between cases and controls with respect to age (‘p’ = 
0.80)
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AGE DISTRIBUTION
7
23
32
38
2
5
28
15
0
5
10
15
20
25
30
35
40
SMOKERS NON
SMOKERS
Upto 30 years 31-40 41-50 51-60
 50
Table 2 
Occupation 
 
Smokers = 100 Non Smokers = 50  
Occupation 
No % No % 
Agriculture 14 14 5 10 
Drivers 11 11 - - 
Carpenter 4 4 - - 
Daily wages labourer 43 43 33 66 
Dhoby 5 5 1 2 
Merchants 2 2 - - 
Load man 18 18 7 14 
Engineer 1 1 - - 
Clerks 2 2 4 8 
 
  
Majority of the case population were daily wages labourer (43%), 
followed by other workers (18%), which included barbers and mechanics. 
Among the control population, majority of them were daily wages labourer 
(66%). 
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Table 3 
Educational Status 
 
Cases (Smokers) Controls (Non 
Smokers) 
 
Occupation 
No % No % 
Illiterates 2 21 8 16 
Upto 5th std 45 45 21 42 
6 – 8 th  std 19 19 14 28 
9 – 12th std 14 14 7 14 
B.E 1 1 - - 
Total 100 100 50 100 
 
 Majority of the case population were found to be educated upto 5th 
standard (45%). Nearly 21% of the case population were found to be illiterate.  
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Table 4 
Family History of Diabetes 
 
Cases (Smokers) Controls (Non 
Smokers) 
 
Family History 
No % No % 
Yes 4 4 - - 
No 96 96 50 100 
P 0.3016 Not Significant 
 
 Among the study population, only 4% of the cases were found to have 
family history of diabetes. 
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Table 5 
Physical Activity 
 
Cases (Smokers) Controls (Non 
Smokers) 
 
Life style (Physical Activity) 
No % No % 
Sedentary 4 4 4 8 
Non – sedentary 96 96 46 92 
P 0.4415 (Not Significant) 
 
  
       Majority of the population study in both cases and controls had non 
sedentary life style. Thus there was no significant difference between cases 
and controls with respect to lifestyle habits (‘p’ = 0.44) 
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Table 6 
Smoking Profiles 
 
Cases = 100 
Controls = 50 
 
Smoking Profile 
No % 
A. Smoking (n = 150) 
a i)  Current smokers 
a ii)  Former smokers 
a) Total smokers 
b) Non smokers 
 
83 
17 
100 
50 
 
55.3 
11.3 
66.6 
33.3 
B. Type of Smoking ( n = 100) 
a) Cigarettes 
b) Bidis 
c) Both 
 
27 
47 
26 
 
27 
47 
26 
 Mean S.D 
C. Duration of smoking in years 20.54 9.75 
D. No. per day 10.15 5.89 
E. Pack years 10.4 8.6 
 
 Majority of the study population were current smokers (55.3%).     
Among the smokers, most of then were found to be Bidi smokers (47%). 
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Table 7 
Physical profile 
Cases (Smokers) Controls (Non 
Smokers) 
 
Parameter 
No % No % 
A. Body mass index(BMI) 
i) Normal (< 25) 
ii) Over weight (25 – 29.9) 
iii) obese (30 and above) 
 
70 
25 
5 
 
70 
25 
5 
 
45 
4 
1 
 
90 
8 
2 
‘P’ 0.0116 Significant 
B. Blood pressure(BP) 
 
i) Normal 
ii) Abnormal 
 
80 
20 
 
80 
20 
 
43 
7 
 
86 
14 
‘P’ 0.4989 Not significant 
C. Waist Circumference 
i) Normal (m < 102  F < 88) 
ii) Abnormal (m > 102 F > 88) 
 
97 
3 
 
97 
3 
 
50 
- 
 
100 
- 
‘P’ 0.5511 Not Significant 
D. Fasting Blood Sugar 
i) Normal (Less than 100mg/dl)
ii) Impaired (100 – 125) 
iii) Diabetes (more than 125) 
 
71 
12 
17 
 
71 
12 
17 
 
39 
11 
- 
 
78 
22 
- 
‘P’ 0.4727 Not significant 
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Nearly 5% of the case population were obese. Among the control 
population, obesity accounted for 2% of them. There was a significant 
statistical difference between cases and controls with respect to BMI (‘p’ = 
0.0116). 
 
 With regard to Blood Pressure, there was no significant statistical   
difference between cases and controls (‘p’ = 0.4989). 
 
 Glucose Intolerance among case population were found to be 29% and   
among the control population, found to be 22%. Thus there was no significant 
statistical difference between cases and controls (‘p’ = 0.4727). 
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Table  8 
Lipid Profile 
 
Cases 
(Smokers) 
Controls (Non 
Smokers) 
 
Parameter 
No % No % 
A. Triglyceride(TGL) 
i) Normal (≤ 150) 
ii) Abnormal (> 150) 
 
47 
53 
 
47 
53 
 
27 
23 
 
54 
46 
‘P’ 0.5253 (Not Significant) 
B. HDL 
i) Normal (≥ 40) 
ii) Abnormal (< 40) 
 
87 
13 
 
87 
13 
 
43 
7 
 
86 
14 
‘P’ 0.9323 (Not Significant) 
 
 53 cases of the study group (53%) had high Triglyceride. 46% of the 
control group had high TG. Thus, there was no significant statistical 
association between study and control group (p =0.52) 
 
 13 cases of the study group (13%) had low HDL. 14% of the control 
group also had low HDL. Thus there was no significant statistical association 
between study and control group (p = 0.93) 
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Table 9  
Metabolic Syndrome 
  
  TGL :Triglyceride ,  HDL :High Density Lipoprotein,  B.P: Blood Pressure 
 
 10% of the case population had metabolic syndrome and 6% of the 
control population had the same. There was no significant statistical 
association 
Smokers  Non Smokers  
Abnormalities No % No % 
a) Central obesity  
(Waist circumference  M > 102 cm  
                                     F > 88 cm) 
3 3 - - 
b) Abnormal TGL (> 150) 53 53 23 46 
c) Abnormal HDL (< 40) 13 13 7 14 
d) Hypertension (systolic B.P ≥ 130, 
Diastolic B.P ≥85) 
20 20 7 14 
e) Fasting blood glucose (≥100) 29 29 11 22 
Metabolic syndrome(any 3 of the 
above) 
10 10 3 6 
‘P’ 0.3127 Not Significant 
 63
 
 METABOLIC SYNDROME
10
90
3
47
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
SMOKERS NON
SMOKERS
PRESENT ABSENT
 64
B. RELATIONSHIP BETWEEN GLYCEMIC STATUS AND 
VARIOUS PARAMETERS. 
 
Table 10 
Age and Glycemic  Status 
 
Age  in years 
Smokers Non smokers Total 
Gly. Status 
Mean SD Mean SD Mean SD 
Normal 46.3 10.8 47.4 6.5 46.7 9.4 
Impaired 
(prediabetes)  
53.4 11.9 48.5 8.5 51.1 10.5 
Diabetes 47.5 9.1 - - 47.5 9.1 
‘P’ 0.2714 
Not Significant 
0.3653 
Not Significant 
0.2009 
Not Significant 
 
 No statistically significant relationship existed between age and 
glycemic status.  
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Table 11 
Glycemic status and smoking 
 
Smokers Total 
Smokers 
Non 
Smokers 
Current Former     
 
 
Gly. Status 
Mean % Mean % Mean % Mean % 
Normal (110) 60 54.5 11 10 71 64.5 39 35.5
Impaired (23) 9 39.1 3 13 12 52.5 11 47.8
Diabetes (17) 14 82.4 3 7.6 17 100 - - 
‘p’ smokers vs 
non smokers 
0.0048 Significant 
Current smokers 
vs non smokers 
0.0055 (Significant) 
Former smokers 
vs non smokers 
0.0142 (Significant) 
Current smokers 
vs Former 
smokers 
0.5884 ( Not significant) 
 
 
 There was a significant statistical association between smoking and 
glycemic status (p = 0.0048). There was no statistically significant difference 
between current smokers and former smokers.  
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Table 12 
Type of Smoking and Glycemic status 
 
 
Glycemic status 
Normal Impaired Diabetes 
Smoking type 
No % No % No % 
Cigarettes (27) 20 74.1 3 11.1 4 14.8 
Bidis (47) 34 72.3 6 12.8 7 14.9 
Both (26) 17 65.4 3 11.5 6 23.1 
 
 There is no significant difference between glycemic status of smokers 
and type of smoking. 
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Table 13 
Metabolic syndrome and smoking 
 
Smokers 
Current Former Total  
Non Smokers  
Metabolic 
syndrome No % No % No % No % 
Present (13) 7 53.8 3 23.1 10 76.9 3 23.1 
Absent (137) 76 55.5 14 10.2 90 65.7 47 34.3 
‘p’ value for Current  
vs nonsmokers 
0.4403  
not significant 
‘p’ value for Former vs 
nonsmokers 
0.167 
 not significant 
‘p’ value for total 
smokers and non-
smokers 
0.5452 
Not significant 
 
  
No statistically significant relationship exist between smoking and 
metabolic syndrome.   
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Table 14 
Pack years and Glycemic Status 
 
Pack years for  
Current smokers Former smokers Total 
 
Glycemic 
Status Mean SD Mean SD Mean SD 
Normal 9.4 8.5 8.9 8.3 9.3 8.4 
Impaired  11.8 7.4 13.4 14.5 12.2 8.9 
Diabetes 12.7 9.1 18.0 6.1 13.6 8.1 
‘p’ 0.1525 Not 
Significant 
0.224 Not 
Significant 
0.0483  
 Significant 
 
Statistically significant. relationship exists between pack years of total 
smokers and glycemic  status (p. 0.0483) 
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Table 15 
Pack years and metabolic syndrome 
 
Pack years for  
Current smokers Former smokers Total 
Metabolic  
syndrome 
Mean SD Mean SD Mean SD 
Present 17.5 17.9 8.4 6.2 14.8 15.5 
Absent 9.5 6.9 11.9 9.9 9.9 7.4 
‘p’ 0.2578  
Not Significant 
0.7526 
Not Significant 
0.4343  
Not Significant 
 
 No statistical significant association exist between pack years and 
metabolic syndrome. 
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Table 16 
Body Mass Index and Metabolic syndrome 
 
BMI  
Metabolic syndrome Mean S.D. 
Present 23.14 3.33 
Absent 24.09 3.85 
‘p’ 0.4706 
Not Significant 
 
 No statistically significant. relationship exists between BMI and 
metabolic syndrome (p.= 0.4706) 
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DISCUSSION 
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DISCUSSION 
 
 Among the 150 participants in my study, 100 of them were smokers. 
Among the 100 smokers, 83 were current smokers and 17 were former 
smokers.  
                         
The mean age of the participants was 47 (SD 10.7) years, majority of 
the smokers had an occupation of daily wages labourers and a low educational 
status  
 
Smoking and Educational status 
In my study, Tobacco consumption in the form of smoking was 
observed more among low educational status (Up to 5th standard – 45%) and 
illiterates (21%), compared to those educated higher (>5th std – 34%) In 
(Rajeev Gupta et al 2006)47 study, the greatest tobacco consumption was 
observed among illiterate (60%) and low education status (51%), compared to 
more literate (6th -10th and > 10 years of formal education-46 and 36% 
respectively) 
 
 Thus, by comparing both thus status, we observe an inverse 
association of education status with tobacco use. In my study, low 
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educational status were found to smoke more compared to illiterate on the 
contrary  of Rajeev et al study.47 
 
 This difference in the above could be explained as follows: My study 
included  100 cases , compared to their study (3148 cases). My study included 
tobacco consumption only in the form of smoking in contrast to their study 
which included  other forms of tobacco use in addition to smoking.    
 
Glucose Intolerance and smoking 
 In my study, 12 participants out of 100 smokers had impaired fasting 
glucose and 17 cases had diabetes. The prevalence of glucose intolerance was 
also higher among smokers than is non smokers (p. =0.004). 
 
A prospective study by Houston et al,31 showed a graded association 
between smoking exposure and the development of glucose Intolerance. The 
15 year incidence of glucose intolerance was highest among smokers (21.8%) 
followed by never smokes with passive smoking exposure (17.2%), and then 
previous smokers (14.4%); It was lowest for never smokers with no passive 
exposure (11.5%). Thus, their study ended up by stating that current smokers 
and never smokers with passive smoking exposure were at higher risk than 
never smokers without passive smokers exposure and risk in previous 
smokers was similar to that is never smokers without passive smoking 
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exposure. In my study, which was a cross sectional study, there was a 
significant statistical association between smoking and glycemic status        
(p’ 0.0048). My study also showed that a statistically significant association 
between current smokers and non smokers (p’ 0.0055) similar to the study by 
Houston et al 31.But, in contrary to the study by Houston et al 31, which said 
that risk is previous smokers was similar to that of never smokers without 
passive smoking exposure, my study showed a significant statistical 
association between former smokers and non smokers (‘p’ 0.0142). This may 
be due to the fact that, my study did not subcategorized never smokers as, 
those with passive exposure and without passive exposure. But, there are 
certain studies which supported the fact that former smokers were also at risk 
for Diabetes. 
        
 
  Carolie et al9 conducted a systematic review and meta-analysis of 
studies describing the association between active smoking and incidence of 
diabetes or other glucose intolerance which also indicated that active smokers 
had 44% increased risk for developing type 2 diabetes compared with Non 
smokers. They also described a significant association between former 
smokers and incidence of diabetes. 
 
In another study by Sulander T. et al59, they found that heavy smokers 
and current smokers were at risk of obesity and diabetes.  
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A study Beziaud et al (2004)8 also concluded that current and past 
smoking were associated with a risk of diabetes mellitus essentially in men. 
Thus the statistical association between former smokers & glycemic status 
was supported by the above studies.  
 
Thus, my study clears correlates with many trials, which showed an 
increased risk of developing diabetes among smokers (current and former). 
 
Type of smoking and glycemic status   
           In the present study, smokers showed an increased risk for glucose 
intolerance, but the type of smoking did not influence the result. 
 
Pack years and glycemic status 
               In my study, the pack years among participants with normal 
glycemic status had a mean of 9.3 (S.D 8.4) ; participants with impaired 
fasting glucose had a mean of 12.2 (S.D 8.9) and those with diabetes had a 
mean of 13.6 (S.D 8.7). Thus, increase in pack years of smoking among the 
participate was associated with an increased risk of developing glucose 
intolerance. 
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 In Houston, et al study31, increase in pack years of smoking over time 
among the 4572 participants was associated with an increased risk of 
developing  glucose intolerance. 
 
 Carolie et al study9 also concluded that there was a dose-response 
relationship, with stronger associations for heavy smokers relative to lighter 
smokers and for active smokers relative to former smokers.  
 
         Thus, use of Pack Years of smoking showed a consistent dose– response 
effect of increasing risk with increasing exposure to tobacco. 
 
 However, In the present study, the dose-response relationship did not 
correlate foractive smokers relative to former smokers. Beziaud et al study8 
found that the association to diabetes was similar in current and former 
smokers, and no dose-effect relationship was found.  
           
         Capri Gabrielle Foy et al study11 found that participants with impaired 
glucose  tolerance were not associated with significantly higher incidence of 
diabetes compared with never smokers.  
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Smoking and BMI 
             We found that among participants, smoking had a significantly higher 
incidence of obesity compared to never smokers.  
                     
            In a study by Sulander T et al study 59(2007)  , they found that, 
“compared to non-smokers, ex-heavy smokers had higher and current light 
smokers lower relative risk of obesity”. 
 
 In another study by Arnaud Chiolero et al13 (2007), obesity was 
associated in a graded manner with the number of cigarettes daily smoked, 
particularly in men. 
 
 Rasky E et al46 (1996) study found that heavy smoking as well as 
smoking  cessation were significantly correlated with higher relative weight.  
 
             Endocrine abstracts20 (2006) also concludes in its study by stating that 
there was a U –shaped association between smoking and BMI. They also 
concluded that heavy smokers were associated with an unhealthy lifestyle, 
which appeared to override weight reducing effect of cigarette smoking. 
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Thus, the present study correlates that smoking is positively related to 
body weight. Most of the participants in our study also found to smoke a lot, 
which also favours our study of increased BMI 
 
Smoking and metabolic syndrome 
            Of the components of the metabolic syndrome, we could find a 
significant association for fasting plasma glucose. but we could not find a 
significant association with  other factors.  
 
           In my study, thus smoking did not show statistically significant 
correlation to metabolic syndrome compared to non smokers. This study is 
somewhat contrary to the general concept that cigarette smoking is 
independently associated with metabolic syndrome.  
 
We suppose that the cross sectional design of this study limited its 
ability to detect these associations.  
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SUMMARY 
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SUMMARY 
 
               The study “IMPACT OF SMOKING ON GLYCEMIC STATUS” 
was conducted among 150 patients attending government Rajaji Hospital, 
Madurai. 
 
           From the patients who satisfied inclusion criteria, study was conducted 
and the relationship between smoking and glucose intolerance was evaluated 
. 
Significant statistical association was noted with respect to the 
following 
• Smoking and glucose intolerance 
• Pack years of smoking and glucose intolerance 
• Smoking and BMI 
No statistically significant relationship was noted for the following 
• Type of smoking and glucose intolerance 
• Smoking and metabolic syndrome 
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CONCLUSION 
 
 
• Tobacco smoking showed a significant positive association with  
glucose intolerance/diabetes, the possible operative mechanisms being 
       1. Smoking stimulate symathetic system, which in   turn   leads to an 
elevated catecholamine levels and there by insulin resistence. 
       2. Smoking influences visceral adipose tissue and there by insulin 
resistance. 
      3. Smokers(especially heavy smokers) are prone for unhealthy food 
habits and  low physical activity which in turn leads to visceral fat 
accumulation and insulin resistance. 
    4. Smoking directly influences insulin sensitivity and impaires insulin 
action. 
• The pack years of exposure showed a significant positive association 
with glucose intolerance/diabetes. The mean packyears among patients 
with glucose intolerance is 11.8 and the mean pack years among 
patients with frank diabetes is 12.7.Thus, the risk of diabetes directly  
correlates with the packyears in my study. As the packyears increases, 
the risk of diabetes also increases. 
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• There is a significant positive association between tobacco smoking 
and increased BMI; this is explainable as follows: smokers are prone  
for unhealthy diet and low physical activity, thus leading on to visceral 
fat accumulation and insulin resistance. 
 
• There is no significant difference among types of smoking (bidis, 
cigarettes, both) and glucose intolerance.  
 
What is already known on this topic 
 
• Smoking is hypothesised to increase insulin resistance. 
 
• Results of previous observational studies assessing the association of  
 
            smoking and incidence of diabetes have been mixed 
 
What this study adds 
  
• A strong positive association existed between tobacco smoking and 
 
            glucose intolerance / frank  diabetes  
 
• Among smokers, total pack years smoked was associated with  
 
            increased risk  of glucose intolerance/diabetes 
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LIMITATIONS 
       
• Some parameters such as serum cotinine concentration (a biochemical 
marker of nicotine uptake) which defines the tobacco exposure level 
was not taken in my study due to non availability of laboratory support. 
 
• Also the present study represents people recruited from those attending 
government Rajaji Hospital in Madurai. Our results are not necessarily 
generalized to other ethnic population. 
 
• My study could not demonstrate the association between smoking and 
metabolic syndrome. 
 
• The cross sectional design of this study prohibited me from concluding 
causal relationship and may have included some bias. We need further 
evidence on the consistency of the association in different populations 
ideally from cohort studies with fasting glucose measurements at 
baseline and follow-up. We also need a well-designed clinical studies 
of the effects of acute and chronic smoking on insulin resistance. 
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 5
ABBREVATIONS 
 
 
PVD   - Peripheral vascular disease 
 
CAD   - Coronary artery disease 
 
PROM  - Premature rupture of membrane 
 
IRDS   -  Infant respiratory distress syndrome 
 
ARMD  -  Age related macular degeneration 
 
HC   -  Hip circumference 
 
WC   - Waist circumference 
 
WHR   - Waist hip ratio 
 
VAT   -  Visceral adipose tissue 
 
BMI   -  Body mass index 
 
OCP   - Oral contraceptive pill 
 
TC   -  Total cholesterol 
 
TGL   -  Triglyceride 
 
 6
HDL   -  High density lipoprotein 
VLDL   -  Very low density lipoprotein 
 
LDL    - Low density lipoprotein 
 
Ht    -  Height 
 
Wt   - Weight 
 
BP   -  Blood pressure 
 
Blood sugar(F) -  Fasting  
 
Blood sugar(pp) -  Postprandial 
 
NCEP: ATPIII -  National Cholesterol Education Programme, Adult  
Treatment Panel III 
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PROFOMA – IMPACT OF SMOKING ON GLYCEMIC STATUS 
 
NAME  
AGE  
SEX  
OCCUPATION  
EDUCATIONAL STATUS  
FAMILY H/O DIABETES  
DIET & PHYSICAL ACTIVITY  
COMORBID ILLNESS 
 
 
SMOKING 
1) NEVER/FURMER/ CURRENT 
2) TYPE OF SMOKING (CIGARS / BIDIS / BOTH) 
3)     NO OF CIGARS ; < 0R > 20 PER WEEK 
 
ALCOHOLISM  
 
EXAMINATION 
1) weight 
2) height 
3) blood pressure 
      4) waist hip ratio 
 
INVESTIGATIONS 
BLOOD SUGAR fasting –  
                              Post prandial 
SERUM LIPID PROFILE (fasting) 
 
 
